Navivumab (anti-HA) 是一种甲型流感病毒 (influenza A virus) 血凝素 HA 单克隆抗体。Navivumab (anti-HA) 通过与 HA2 中的茎融合结构域结合来中和 H1、H2、H5 和 H9 甲型流感病毒。
Navivumab (anti-HA) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2.
规格
产品名称
Navivumab (anti-HA)
别名
那韦伏单抗
英文别名
Hemagglutinin | haemagglutinin | Influenza A Virus antibody | HA | CT-P23
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片
Navivumab (anti-HA) (Ab191936) - ELISA Immobilized Recombinant HA/Hemagglutinin, H1N1 (sf9, His) protein at 2.0 μg/mL can bind Navivumab (anti-HA) (Ab191936) with the EC₅₀ of 7.59 ng/mL.
Navivumab (anti-HA) (Ab191936) - SEC The purity of Navivumab (anti-HA) (Ab191936) is more than 95% verified by HPLC.